Cefepime pharmacodynamics in patients with extended spectrum β-lactamase (ESBL) and non-ESBL infections
Authors:
- David P. NicolauDNDavid P. Nicolau
- 1 May 2007
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 54 (5) , 463-468
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical implications of extended spectrum β-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectivenessJournal of Infection, 2005
- Determination of the In Vivo Pharmacodynamic Profile of Cefepime against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli at Various InoculaAntimicrobial Agents and Chemotherapy, 2004
- Pharmacodynamics of cefepime in patients with Gram-negative infectionsJournal of Antimicrobial Chemotherapy, 2002
- Cefepime, Piperacillin-Tazobactam, and the Inoculum Effect in Tests with Extended-Spectrum β-Lactamase-Producing EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2001
- Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology LaboratoryJournal of Clinical Microbiology, 2001
- In Vitro and In Vivo Activities of Amikacin, Cefepime, Amikacin plus Cefepime, and Imipenem against an SHV-5 Extended-Spectrum β-Lactamase-ProducingKlebsiella pneumoniaeStrainAntimicrobial Agents and Chemotherapy, 2001
- Is continuous infusion of β-lactam antibiotics worthwhile?—efficacy and pharmacokinetic considerationsJournal of Antimicrobial Chemotherapy, 1996
- Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporinsDiagnostic Microbiology and Infectious Disease, 1995
- In-vitro activity of cefepime and other antimicrobials: Survey of European isolatesJournal of Antimicrobial Chemotherapy, 1993
- In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic Gram-negative bacilliJournal of Antimicrobial Chemotherapy, 1993